Learn more about whether Biogen Inc. or Exact Sciences Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Learn more about whether Biogen Inc. or Gilead Sciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Talkiatry, a leading provider of high-quality, in-network psychiatric care, today announced that it has been named to the 2025 New York Digital Health 100 (DH100), a recognition that highlights the ...

Launched in 2018, the Morningstar Minority Empowerment Index highlights companies that demonstrate a strong commitment to ...

Older studies estimated a lower risk of dementia. According to new research, the number of people living with the disease in the U.S. is expected to double by 2060.

Financial writer recommends Voyager Therapeutics, Inc. for high-risk investors due to promising preclinical Alzheimer's ...

The first day of the J.P. Morgan Healthcare Conference is in the books, featuring high-profile deal announcements ... s disease treatment last year, Biogen CEO Chris Viehbacher said his company ...

Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatment Alzheimer's disease progression does not stop after plaque clearance; ongoing treatment with ...

Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatmentAlzheimer's disease progression does ...

Eisai Co., Ltd. and Biogen Inc. have announced that the ... and severe in 1% of patients. Resolution on MRI occurred in 52% of ARIA-E patients by 12 weeks, 81% by 17 weeks, and 100% overall ...

President Donald Trump issued executive orders late Friday reviving some of his first term’s anti-abortion policies, like ...